» Articles » PMID: 36814601

The Role of WNT10B in Physiology and Disease: A 10-year Update

Overview
Specialty Cell Biology
Date 2023 Feb 23
PMID 36814601
Authors
Affiliations
Soon will be listed here.
Abstract

WNT10B, a member of the WNT family of secreted glycoproteins, activates the WNT/β-catenin signaling cascade to control proliferation, stemness, pluripotency, and cell fate decisions. WNT10B plays roles in many tissues, including bone, adipocytes, skin, hair, muscle, placenta, and the immune system. Aberrant WNT10B signaling leads to several diseases, such as osteoporosis, obesity, split-hand/foot malformation (SHFM), fibrosis, dental anomalies, and cancer. We reviewed WNT10B a decade ago, and here we provide a comprehensive update to the field. Novel research on WNT10B has expanded to many more tissues and diseases. polymorphisms and mutations correlate with many phenotypes, including bone mineral density, obesity, pig litter size, dog elbow dysplasia, and cow body size. In addition, the field has focused on the regulation of using upstream mediators, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). We also discussed the therapeutic implications of WNT10B regulation. In summary, research conducted during 2012-2022 revealed several new, diverse functions in the role of WNT10B in physiology and disease.

Citing Articles

A review of mathematical modeling of bone remodeling from a systems biology perspective.

Cook C, Lighty A, Smith B, Ford Versypt A Front Syst Biol. 2025; 4.

PMID: 40012834 PMC: 11864782. DOI: 10.3389/fsysb.2024.1368555.


Emerging roles and biomarker potential of WNT6 in human cancers.

Ferreira J, Goncalves C, Costa B Cell Commun Signal. 2024; 22(1):538.

PMID: 39529066 PMC: 11552340. DOI: 10.1186/s12964-024-01892-4.


Suppressive Potential of L. Extract against Triple-Negative and Luminal A Breast Cancer.

Eghbalpour K, Eghbalpour N, Khademi S, Arzi L Int J Mol Cell Med. 2024; 13(2):198-209.

PMID: 39184822 PMC: 11344568. DOI: 10.22088/IJMCM.BUMS.13.2.198.


Targeting WNT5B and WNT10B in osteosarcoma.

Miranda-Carboni G, Krum S Oncotarget. 2024; 15:535-540.

PMID: 39102216 PMC: 11299661. DOI: 10.18632/oncotarget.28617.


Bimaxillary fixed implant-supported zirconium oxide prosthesis therapy of an adolescent patient with non-syndromic oligodontia and two WNT10 variants: a case report.

Grun P, Pfaffeneder-Mantai F, Leunig N, Bytyqi D, Maier C, Gencik M Ann Med Surg (Lond). 2024; 86(5):3072-3081.

PMID: 38694351 PMC: 11060206. DOI: 10.1097/MS9.0000000000001936.


References
1.
Aoi N, Inoue K, Chikanishi T, Fujiki R, Yamamoto H, Kato H . 1α,25-dihydroxyvitamin D3 modulates the hair-inductive capacity of dermal papilla cells: therapeutic potential for hair regeneration. Stem Cells Transl Med. 2012; 1(8):615-26. PMC: 3659730. DOI: 10.5966/sctm.2012-0032. View

2.
DaSilva-Arnold S, James J, Al-Khan A, Zamudio S, Illsley N . Differentiation of first trimester cytotrophoblast to extravillous trophoblast involves an epithelial-mesenchymal transition. Placenta. 2015; 36(12):1412-8. DOI: 10.1016/j.placenta.2015.10.013. View

3.
Frey J, Li Z, Ellis J, Zhang Q, Farber C, Aja S . Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast. Mol Cell Biol. 2015; 35(11):1979-91. PMC: 4420919. DOI: 10.1128/MCB.01343-14. View

4.
Zhou F, Lei Y, Xu X, Zhou H, Liu H, Jiang J . LINC00355:8 promotes cell proliferation and migration with invasion the MiR-6777-3p/Wnt10b axis in Hepatocellular Carcinoma. J Cancer. 2020; 11(19):5641-5655. PMC: 7477441. DOI: 10.7150/jca.43831. View

5.
Brun J, Dieudonne F, Marty C, Muller J, Schule R, Patino-Garcia A . FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo. PLoS One. 2013; 8(1):e55034. PMC: 3557236. DOI: 10.1371/journal.pone.0055034. View